Posted by Michael Wonder on 21 Oct 2020
FDA approves fewer generics in FY2020, ending record streak
21 October 2020 - After four straight years of posting record numbers of abbreviated new drug application approvals, the US FDA has broken its streak, approving 22% fewer generic drugs in FY2020 than it did in FY2019.
In FY2020, FDA approved a total of 909 abbreviated new drug applications, 737 full approvals and 172 tentative approvals, compared to a record 1,171 abbreviated new drug applications in FY2019.
